Please login to the form below

Not currently logged in


This page shows the latest dexamethasone news and features for those working in and with pharma, biotech and healthcare.

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

Sanofi signs $1bn licence agreement for Eureka’s novel multiple myeloma drug

inhibitor. It was cleared for use in combination with pomalidomide and dexamethasone (pom-dex), a standard regimen for the treatment of myeloma.

Latest news

More from news
Approximately 4 fully matching, plus 115 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...